%1 services
Name | Description | ELIXIR Node |
---|---|---|
Comparison, benchmarking and dissemination of proteomics data analysis pipelines
|
This project will be led by the ELIXIR Proteomics Community in collaboration with members of the Metabolomics Community and three ELIXIR platforms. High-throughput proteomics has become a popular choice in biological, biomedical and clinical studies and led to the development of hundreds of bioinformatics tools and data analysis pipelines. Given their large diversity, there is a urgent need to compare and benchmark different software pipelines over a large data spectrum. This study aims to create the framework to benchmark proteomics data analysis workflows, to be built upon and improve resources from ELIXIR Tool, Data and Compute platforms by creating an interface between them linked with public proteomics data and open source stand-alone software and pipelines. The involved data will be annotated with at least EOSC minimum information according to ELIXIR metadata standards. Our benchmarking will identify robust workflows and therefore nurture the proteomics community with high quality standards required for reproducible research and clinical applications. |
ELIXIR Denmark, EMBL-EBI, ELIXIR Netherlands, ELIXIR Spain, ELIXIR France, ELIXIR Sweden, ELIXIR Italy, ELIXIR Czech Republic, ELIXIR Germany |
Comparison, benchmarking and dissemination of proteomics data analysis pipelines
|
This project will be led by the ELIXIR Proteomics Community in collaboration with members of the Metabolomics Community and three ELIXIR platforms. High-throughput proteomics has become a popular choice in biological, biomedical and clinical studies and led to the development of hundreds of bioinformatics tools and data analysis pipelines. Given their large diversity, there is a urgent need to compare and benchmark different software pipelines over a large data spectrum. This study aims to create the framework to benchmark proteomics data analysis workflows, to be built upon and improve resources from ELIXIR Tool, Data and Compute platforms by creating an interface between them linked with public proteomics data and open source stand-alone software and pipelines. The involved data will be annotated with at least EOSC minimum information according to ELIXIR metadata standards. Our benchmarking will identify robust workflows and therefore nurture the proteomics community with high quality standards required for reproducible research and clinical applications. |
ELIXIR Denmark, EMBL-EBI, ELIXIR Netherlands, ELIXIR Spain, ELIXIR France, ELIXIR Sweden, ELIXIR Italy, ELIXIR Czech Republic, ELIXIR Germany |
Comparison, benchmarking and dissemination of proteomics data analysis pipelines
|
This project will be led by the ELIXIR Proteomics Community in collaboration with members of the Metabolomics Community and three ELIXIR platforms. High-throughput proteomics has become a popular choice in biological, biomedical and clinical studies and led to the development of hundreds of bioinformatics tools and data analysis pipelines. Given their large diversity, there is a urgent need to compare and benchmark different software pipelines over a large data spectrum. This study aims to create the framework to benchmark proteomics data analysis workflows, to be built upon and improve resources from ELIXIR Tool, Data and Compute platforms by creating an interface between them linked with public proteomics data and open source stand-alone software and pipelines. The involved data will be annotated with at least EOSC minimum information according to ELIXIR metadata standards. Our benchmarking will identify robust workflows and therefore nurture the proteomics community with high quality standards required for reproducible research and clinical applications. |
ELIXIR Denmark, EMBL-EBI, ELIXIR Netherlands, ELIXIR Spain, ELIXIR France, ELIXIR Sweden, ELIXIR Italy, ELIXIR Czech Republic, ELIXIR Germany |
Comparison, benchmarking and dissemination of proteomics data analysis pipelines
|
This project will be led by the ELIXIR Proteomics Community in collaboration with members of the Metabolomics Community and three ELIXIR platforms. High-throughput proteomics has become a popular choice in biological, biomedical and clinical studies and led to the development of hundreds of bioinformatics tools and data analysis pipelines. Given their large diversity, there is a urgent need to compare and benchmark different software pipelines over a large data spectrum. This study aims to create the framework to benchmark proteomics data analysis workflows, to be built upon and improve resources from ELIXIR Tool, Data and Compute platforms by creating an interface between them linked with public proteomics data and open source stand-alone software and pipelines. The involved data will be annotated with at least EOSC minimum information according to ELIXIR metadata standards. Our benchmarking will identify robust workflows and therefore nurture the proteomics community with high quality standards required for reproducible research and clinical applications. |
ELIXIR Denmark, EMBL-EBI, ELIXIR Netherlands, ELIXIR Spain, ELIXIR France, ELIXIR Sweden, ELIXIR Italy, ELIXIR Czech Republic, ELIXIR Germany |
Comparison, benchmarking and dissemination of proteomics data analysis pipelines
|
This project will be led by the ELIXIR Proteomics Community in collaboration with members of the Metabolomics Community and three ELIXIR platforms. High-throughput proteomics has become a popular choice in biological, biomedical and clinical studies and led to the development of hundreds of bioinformatics tools and data analysis pipelines. Given their large diversity, there is a urgent need to compare and benchmark different software pipelines over a large data spectrum. This study aims to create the framework to benchmark proteomics data analysis workflows, to be built upon and improve resources from ELIXIR Tool, Data and Compute platforms by creating an interface between them linked with public proteomics data and open source stand-alone software and pipelines. The involved data will be annotated with at least EOSC minimum information according to ELIXIR metadata standards. Our benchmarking will identify robust workflows and therefore nurture the proteomics community with high quality standards required for reproducible research and clinical applications. |
ELIXIR Denmark, EMBL-EBI, ELIXIR Netherlands, ELIXIR Spain, ELIXIR France, ELIXIR Sweden, ELIXIR Italy, ELIXIR Czech Republic, ELIXIR Germany |
Comparison, benchmarking and dissemination of proteomics data analysis pipelines
|
This project will be led by the ELIXIR Proteomics Community in collaboration with members of the Metabolomics Community and three ELIXIR platforms. High-throughput proteomics has become a popular choice in biological, biomedical and clinical studies and led to the development of hundreds of bioinformatics tools and data analysis pipelines. Given their large diversity, there is a urgent need to compare and benchmark different software pipelines over a large data spectrum. This study aims to create the framework to benchmark proteomics data analysis workflows, to be built upon and improve resources from ELIXIR Tool, Data and Compute platforms by creating an interface between them linked with public proteomics data and open source stand-alone software and pipelines. The involved data will be annotated with at least EOSC minimum information according to ELIXIR metadata standards. Our benchmarking will identify robust workflows and therefore nurture the proteomics community with high quality standards required for reproducible research and clinical applications. |
ELIXIR Denmark, EMBL-EBI, ELIXIR Netherlands, ELIXIR Spain, ELIXIR France, ELIXIR Sweden, ELIXIR Italy, ELIXIR Czech Republic, ELIXIR Germany |
Comparison, benchmarking and dissemination of proteomics data analysis pipelines
|
This project will be led by the ELIXIR Proteomics Community in collaboration with members of the Metabolomics Community and three ELIXIR platforms. High-throughput proteomics has become a popular choice in biological, biomedical and clinical studies and led to the development of hundreds of bioinformatics tools and data analysis pipelines. Given their large diversity, there is a urgent need to compare and benchmark different software pipelines over a large data spectrum. This study aims to create the framework to benchmark proteomics data analysis workflows, to be built upon and improve resources from ELIXIR Tool, Data and Compute platforms by creating an interface between them linked with public proteomics data and open source stand-alone software and pipelines. The involved data will be annotated with at least EOSC minimum information according to ELIXIR metadata standards. Our benchmarking will identify robust workflows and therefore nurture the proteomics community with high quality standards required for reproducible research and clinical applications. |
ELIXIR Denmark, EMBL-EBI, ELIXIR Netherlands, ELIXIR Spain, ELIXIR France, ELIXIR Sweden, ELIXIR Italy, ELIXIR Czech Republic, ELIXIR Germany |
Comparison, benchmarking and dissemination of proteomics data analysis pipelines
|
This project will be led by the ELIXIR Proteomics Community in collaboration with members of the Metabolomics Community and three ELIXIR platforms. High-throughput proteomics has become a popular choice in biological, biomedical and clinical studies and led to the development of hundreds of bioinformatics tools and data analysis pipelines. Given their large diversity, there is a urgent need to compare and benchmark different software pipelines over a large data spectrum. This study aims to create the framework to benchmark proteomics data analysis workflows, to be built upon and improve resources from ELIXIR Tool, Data and Compute platforms by creating an interface between them linked with public proteomics data and open source stand-alone software and pipelines. The involved data will be annotated with at least EOSC minimum information according to ELIXIR metadata standards. Our benchmarking will identify robust workflows and therefore nurture the proteomics community with high quality standards required for reproducible research and clinical applications. |
ELIXIR Denmark, EMBL-EBI, ELIXIR Netherlands, ELIXIR Spain, ELIXIR France, ELIXIR Sweden, ELIXIR Italy, ELIXIR Czech Republic, ELIXIR Germany |
Comparison, benchmarking and dissemination of proteomics data analysis pipelines
|
This project will be led by the ELIXIR Proteomics Community in collaboration with members of the Metabolomics Community and three ELIXIR platforms. High-throughput proteomics has become a popular choice in biological, biomedical and clinical studies and led to the development of hundreds of bioinformatics tools and data analysis pipelines. Given their large diversity, there is a urgent need to compare and benchmark different software pipelines over a large data spectrum. This study aims to create the framework to benchmark proteomics data analysis workflows, to be built upon and improve resources from ELIXIR Tool, Data and Compute platforms by creating an interface between them linked with public proteomics data and open source stand-alone software and pipelines. The involved data will be annotated with at least EOSC minimum information according to ELIXIR metadata standards. Our benchmarking will identify robust workflows and therefore nurture the proteomics community with high quality standards required for reproducible research and clinical applications. |
ELIXIR Denmark, EMBL-EBI, ELIXIR Netherlands, ELIXIR Spain, ELIXIR France, ELIXIR Sweden, ELIXIR Italy, ELIXIR Czech Republic, ELIXIR Germany |
Data Validation
|
The aim of this Implementation Study is to determine the requirements for validation with ELIXIR partners, to build prototype open validation services for archetype archival databases and knowledge bases, in particular:
|
ELIXIR Belgium , ELIXIR France, EMBL-EBI, ELIXIR UK |
Data Validation
|
The aim of this Implementation Study is to determine the requirements for validation with ELIXIR partners, to build prototype open validation services for archetype archival databases and knowledge bases, in particular:
|
ELIXIR Belgium , ELIXIR France, EMBL-EBI, ELIXIR UK |
Data Validation
|
The aim of this Implementation Study is to determine the requirements for validation with ELIXIR partners, to build prototype open validation services for archetype archival databases and knowledge bases, in particular:
|
ELIXIR Belgium , ELIXIR France, EMBL-EBI, ELIXIR UK |
Data Validation
|
The aim of this Implementation Study is to determine the requirements for validation with ELIXIR partners, to build prototype open validation services for archetype archival databases and knowledge bases, in particular:
|
ELIXIR Belgium , ELIXIR France, EMBL-EBI, ELIXIR UK |
ELIXIR integration from a user perspective
|
ELIXIR is about integration of diverse resources including tools, training materials and technical services. Within EXCELERATE, ELIXIR is building portals to collate information on tools and data services (bio.tools), training events and material (TeSS, WP11 e-learning environment), compute resources (WP4 technical service registry) and cross-linked policy, standards and databases (FAIRsharing, WP4). A focus of EXCELERATE is to set up these portals such that they can interoperate. |
ELIXIR UK, ELIXIR Estonia, ELIXIR Belgium , ELIXIR Denmark, ELIXIR Switzerland, EMBL-EBI, ELIXIR Norway, ELIXIR France |
ELIXIR integration from a user perspective
|
ELIXIR is about integration of diverse resources including tools, training materials and technical services. Within EXCELERATE, ELIXIR is building portals to collate information on tools and data services (bio.tools), training events and material (TeSS, WP11 e-learning environment), compute resources (WP4 technical service registry) and cross-linked policy, standards and databases (FAIRsharing, WP4). A focus of EXCELERATE is to set up these portals such that they can interoperate. |
ELIXIR UK, ELIXIR Estonia, ELIXIR Belgium , ELIXIR Denmark, ELIXIR Switzerland, EMBL-EBI, ELIXIR Norway, ELIXIR France |
ELIXIR integration from a user perspective
|
ELIXIR is about integration of diverse resources including tools, training materials and technical services. Within EXCELERATE, ELIXIR is building portals to collate information on tools and data services (bio.tools), training events and material (TeSS, WP11 e-learning environment), compute resources (WP4 technical service registry) and cross-linked policy, standards and databases (FAIRsharing, WP4). A focus of EXCELERATE is to set up these portals such that they can interoperate. |
ELIXIR UK, ELIXIR Estonia, ELIXIR Belgium , ELIXIR Denmark, ELIXIR Switzerland, EMBL-EBI, ELIXIR Norway, ELIXIR France |
ELIXIR integration from a user perspective
|
ELIXIR is about integration of diverse resources including tools, training materials and technical services. Within EXCELERATE, ELIXIR is building portals to collate information on tools and data services (bio.tools), training events and material (TeSS, WP11 e-learning environment), compute resources (WP4 technical service registry) and cross-linked policy, standards and databases (FAIRsharing, WP4). A focus of EXCELERATE is to set up these portals such that they can interoperate. |
ELIXIR UK, ELIXIR Estonia, ELIXIR Belgium , ELIXIR Denmark, ELIXIR Switzerland, EMBL-EBI, ELIXIR Norway, ELIXIR France |
ELIXIR integration from a user perspective
|
ELIXIR is about integration of diverse resources including tools, training materials and technical services. Within EXCELERATE, ELIXIR is building portals to collate information on tools and data services (bio.tools), training events and material (TeSS, WP11 e-learning environment), compute resources (WP4 technical service registry) and cross-linked policy, standards and databases (FAIRsharing, WP4). A focus of EXCELERATE is to set up these portals such that they can interoperate. |
ELIXIR UK, ELIXIR Estonia, ELIXIR Belgium , ELIXIR Denmark, ELIXIR Switzerland, EMBL-EBI, ELIXIR Norway, ELIXIR France |
ELIXIR integration from a user perspective
|
ELIXIR is about integration of diverse resources including tools, training materials and technical services. Within EXCELERATE, ELIXIR is building portals to collate information on tools and data services (bio.tools), training events and material (TeSS, WP11 e-learning environment), compute resources (WP4 technical service registry) and cross-linked policy, standards and databases (FAIRsharing, WP4). A focus of EXCELERATE is to set up these portals such that they can interoperate. |
ELIXIR UK, ELIXIR Estonia, ELIXIR Belgium , ELIXIR Denmark, ELIXIR Switzerland, EMBL-EBI, ELIXIR Norway, ELIXIR France |
ELIXIR integration from a user perspective
|
ELIXIR is about integration of diverse resources including tools, training materials and technical services. Within EXCELERATE, ELIXIR is building portals to collate information on tools and data services (bio.tools), training events and material (TeSS, WP11 e-learning environment), compute resources (WP4 technical service registry) and cross-linked policy, standards and databases (FAIRsharing, WP4). A focus of EXCELERATE is to set up these portals such that they can interoperate. |
ELIXIR UK, ELIXIR Estonia, ELIXIR Belgium , ELIXIR Denmark, ELIXIR Switzerland, EMBL-EBI, ELIXIR Norway, ELIXIR France |
ELIXIR integration from a user perspective
|
ELIXIR is about integration of diverse resources including tools, training materials and technical services. Within EXCELERATE, ELIXIR is building portals to collate information on tools and data services (bio.tools), training events and material (TeSS, WP11 e-learning environment), compute resources (WP4 technical service registry) and cross-linked policy, standards and databases (FAIRsharing, WP4). A focus of EXCELERATE is to set up these portals such that they can interoperate. |
ELIXIR UK, ELIXIR Estonia, ELIXIR Belgium , ELIXIR Denmark, ELIXIR Switzerland, EMBL-EBI, ELIXIR Norway, ELIXIR France |
Metabolite Identification
|
Metabolomics aims to provide novel insights into the biochemical reactions of organisms by characterising the presence and concentrations of low molecular weight compounds from biological samples. The primary analytical tools for such high-throughput data collection are mass spectrometry (MS), often preceded by chromatographic or electrophoretic separation technologies, and nuclear magnetic resonance spectroscopy (NMR). These technologies produce relatively large and complex data sets that require bioinformaticians, cheminformaticians, biostatisticians, data scientists and computer scientists. Together they develop and apply a wide range of algorithms, software tools, repositories and computational resources to process, analyse, report and store the data and metadata. Increasingly, insights from genomics, epigenomics, transcriptomics, proteomics/protein interactomics and metabolomics are combined, to gain insights into the dynamics of biological processes. Metabolomics activities are well represented within Europe and ELIXIR nodes. Metabolite identification is the area that the community believes will have maximal impact of computational metabolomics and metabolomics data management and will benefit most from interactions with the existing five ELIXIR platforms and where progress will contribute most to other ELIXIR communities. The progress through this integrative Implementation Study will benefit industry and academia alike as metabolite identification is one of the major bottlenecks in metabolomics and resolving this challenge requires a community effort. |
ELIXIR Netherlands, EMBL-EBI, ELIXIR France, ELIXIR UK, ELIXIR Germany, ELIXIR Spain, ELIXIR Sweden, ELIXIR Italy, ELIXIR Estonia, ELIXIR Switzerland, ELIXIR Belgium |
Metabolite Identification
|
Metabolomics aims to provide novel insights into the biochemical reactions of organisms by characterising the presence and concentrations of low molecular weight compounds from biological samples. The primary analytical tools for such high-throughput data collection are mass spectrometry (MS), often preceded by chromatographic or electrophoretic separation technologies, and nuclear magnetic resonance spectroscopy (NMR). These technologies produce relatively large and complex data sets that require bioinformaticians, cheminformaticians, biostatisticians, data scientists and computer scientists. Together they develop and apply a wide range of algorithms, software tools, repositories and computational resources to process, analyse, report and store the data and metadata. Increasingly, insights from genomics, epigenomics, transcriptomics, proteomics/protein interactomics and metabolomics are combined, to gain insights into the dynamics of biological processes. Metabolomics activities are well represented within Europe and ELIXIR nodes. Metabolite identification is the area that the community believes will have maximal impact of computational metabolomics and metabolomics data management and will benefit most from interactions with the existing five ELIXIR platforms and where progress will contribute most to other ELIXIR communities. The progress through this integrative Implementation Study will benefit industry and academia alike as metabolite identification is one of the major bottlenecks in metabolomics and resolving this challenge requires a community effort. |
ELIXIR Netherlands, EMBL-EBI, ELIXIR France, ELIXIR UK, ELIXIR Germany, ELIXIR Spain, ELIXIR Sweden, ELIXIR Italy, ELIXIR Estonia, ELIXIR Switzerland, ELIXIR Belgium |
Metabolite Identification
|
Metabolomics aims to provide novel insights into the biochemical reactions of organisms by characterising the presence and concentrations of low molecular weight compounds from biological samples. The primary analytical tools for such high-throughput data collection are mass spectrometry (MS), often preceded by chromatographic or electrophoretic separation technologies, and nuclear magnetic resonance spectroscopy (NMR). These technologies produce relatively large and complex data sets that require bioinformaticians, cheminformaticians, biostatisticians, data scientists and computer scientists. Together they develop and apply a wide range of algorithms, software tools, repositories and computational resources to process, analyse, report and store the data and metadata. Increasingly, insights from genomics, epigenomics, transcriptomics, proteomics/protein interactomics and metabolomics are combined, to gain insights into the dynamics of biological processes. Metabolomics activities are well represented within Europe and ELIXIR nodes. Metabolite identification is the area that the community believes will have maximal impact of computational metabolomics and metabolomics data management and will benefit most from interactions with the existing five ELIXIR platforms and where progress will contribute most to other ELIXIR communities. The progress through this integrative Implementation Study will benefit industry and academia alike as metabolite identification is one of the major bottlenecks in metabolomics and resolving this challenge requires a community effort. |
ELIXIR Netherlands, EMBL-EBI, ELIXIR France, ELIXIR UK, ELIXIR Germany, ELIXIR Spain, ELIXIR Sweden, ELIXIR Italy, ELIXIR Estonia, ELIXIR Switzerland, ELIXIR Belgium |
Metabolite Identification
|
Metabolomics aims to provide novel insights into the biochemical reactions of organisms by characterising the presence and concentrations of low molecular weight compounds from biological samples. The primary analytical tools for such high-throughput data collection are mass spectrometry (MS), often preceded by chromatographic or electrophoretic separation technologies, and nuclear magnetic resonance spectroscopy (NMR). These technologies produce relatively large and complex data sets that require bioinformaticians, cheminformaticians, biostatisticians, data scientists and computer scientists. Together they develop and apply a wide range of algorithms, software tools, repositories and computational resources to process, analyse, report and store the data and metadata. Increasingly, insights from genomics, epigenomics, transcriptomics, proteomics/protein interactomics and metabolomics are combined, to gain insights into the dynamics of biological processes. Metabolomics activities are well represented within Europe and ELIXIR nodes. Metabolite identification is the area that the community believes will have maximal impact of computational metabolomics and metabolomics data management and will benefit most from interactions with the existing five ELIXIR platforms and where progress will contribute most to other ELIXIR communities. The progress through this integrative Implementation Study will benefit industry and academia alike as metabolite identification is one of the major bottlenecks in metabolomics and resolving this challenge requires a community effort. |
ELIXIR Netherlands, EMBL-EBI, ELIXIR France, ELIXIR UK, ELIXIR Germany, ELIXIR Spain, ELIXIR Sweden, ELIXIR Italy, ELIXIR Estonia, ELIXIR Switzerland, ELIXIR Belgium |
Metabolite Identification
|
Metabolomics aims to provide novel insights into the biochemical reactions of organisms by characterising the presence and concentrations of low molecular weight compounds from biological samples. The primary analytical tools for such high-throughput data collection are mass spectrometry (MS), often preceded by chromatographic or electrophoretic separation technologies, and nuclear magnetic resonance spectroscopy (NMR). These technologies produce relatively large and complex data sets that require bioinformaticians, cheminformaticians, biostatisticians, data scientists and computer scientists. Together they develop and apply a wide range of algorithms, software tools, repositories and computational resources to process, analyse, report and store the data and metadata. Increasingly, insights from genomics, epigenomics, transcriptomics, proteomics/protein interactomics and metabolomics are combined, to gain insights into the dynamics of biological processes. Metabolomics activities are well represented within Europe and ELIXIR nodes. Metabolite identification is the area that the community believes will have maximal impact of computational metabolomics and metabolomics data management and will benefit most from interactions with the existing five ELIXIR platforms and where progress will contribute most to other ELIXIR communities. The progress through this integrative Implementation Study will benefit industry and academia alike as metabolite identification is one of the major bottlenecks in metabolomics and resolving this challenge requires a community effort. |
ELIXIR Netherlands, EMBL-EBI, ELIXIR France, ELIXIR UK, ELIXIR Germany, ELIXIR Spain, ELIXIR Sweden, ELIXIR Italy, ELIXIR Estonia, ELIXIR Switzerland, ELIXIR Belgium |
Metabolite Identification
|
Metabolomics aims to provide novel insights into the biochemical reactions of organisms by characterising the presence and concentrations of low molecular weight compounds from biological samples. The primary analytical tools for such high-throughput data collection are mass spectrometry (MS), often preceded by chromatographic or electrophoretic separation technologies, and nuclear magnetic resonance spectroscopy (NMR). These technologies produce relatively large and complex data sets that require bioinformaticians, cheminformaticians, biostatisticians, data scientists and computer scientists. Together they develop and apply a wide range of algorithms, software tools, repositories and computational resources to process, analyse, report and store the data and metadata. Increasingly, insights from genomics, epigenomics, transcriptomics, proteomics/protein interactomics and metabolomics are combined, to gain insights into the dynamics of biological processes. Metabolomics activities are well represented within Europe and ELIXIR nodes. Metabolite identification is the area that the community believes will have maximal impact of computational metabolomics and metabolomics data management and will benefit most from interactions with the existing five ELIXIR platforms and where progress will contribute most to other ELIXIR communities. The progress through this integrative Implementation Study will benefit industry and academia alike as metabolite identification is one of the major bottlenecks in metabolomics and resolving this challenge requires a community effort. |
ELIXIR Netherlands, EMBL-EBI, ELIXIR France, ELIXIR UK, ELIXIR Germany, ELIXIR Spain, ELIXIR Sweden, ELIXIR Italy, ELIXIR Estonia, ELIXIR Switzerland, ELIXIR Belgium |
Metabolite Identification
|
Metabolomics aims to provide novel insights into the biochemical reactions of organisms by characterising the presence and concentrations of low molecular weight compounds from biological samples. The primary analytical tools for such high-throughput data collection are mass spectrometry (MS), often preceded by chromatographic or electrophoretic separation technologies, and nuclear magnetic resonance spectroscopy (NMR). These technologies produce relatively large and complex data sets that require bioinformaticians, cheminformaticians, biostatisticians, data scientists and computer scientists. Together they develop and apply a wide range of algorithms, software tools, repositories and computational resources to process, analyse, report and store the data and metadata. Increasingly, insights from genomics, epigenomics, transcriptomics, proteomics/protein interactomics and metabolomics are combined, to gain insights into the dynamics of biological processes. Metabolomics activities are well represented within Europe and ELIXIR nodes. Metabolite identification is the area that the community believes will have maximal impact of computational metabolomics and metabolomics data management and will benefit most from interactions with the existing five ELIXIR platforms and where progress will contribute most to other ELIXIR communities. The progress through this integrative Implementation Study will benefit industry and academia alike as metabolite identification is one of the major bottlenecks in metabolomics and resolving this challenge requires a community effort. |
ELIXIR Netherlands, EMBL-EBI, ELIXIR France, ELIXIR UK, ELIXIR Germany, ELIXIR Spain, ELIXIR Sweden, ELIXIR Italy, ELIXIR Estonia, ELIXIR Switzerland, ELIXIR Belgium |
Metabolite Identification
|
Metabolomics aims to provide novel insights into the biochemical reactions of organisms by characterising the presence and concentrations of low molecular weight compounds from biological samples. The primary analytical tools for such high-throughput data collection are mass spectrometry (MS), often preceded by chromatographic or electrophoretic separation technologies, and nuclear magnetic resonance spectroscopy (NMR). These technologies produce relatively large and complex data sets that require bioinformaticians, cheminformaticians, biostatisticians, data scientists and computer scientists. Together they develop and apply a wide range of algorithms, software tools, repositories and computational resources to process, analyse, report and store the data and metadata. Increasingly, insights from genomics, epigenomics, transcriptomics, proteomics/protein interactomics and metabolomics are combined, to gain insights into the dynamics of biological processes. Metabolomics activities are well represented within Europe and ELIXIR nodes. Metabolite identification is the area that the community believes will have maximal impact of computational metabolomics and metabolomics data management and will benefit most from interactions with the existing five ELIXIR platforms and where progress will contribute most to other ELIXIR communities. The progress through this integrative Implementation Study will benefit industry and academia alike as metabolite identification is one of the major bottlenecks in metabolomics and resolving this challenge requires a community effort. |
ELIXIR Netherlands, EMBL-EBI, ELIXIR France, ELIXIR UK, ELIXIR Germany, ELIXIR Spain, ELIXIR Sweden, ELIXIR Italy, ELIXIR Estonia, ELIXIR Switzerland, ELIXIR Belgium |
Metabolite Identification
|
Metabolomics aims to provide novel insights into the biochemical reactions of organisms by characterising the presence and concentrations of low molecular weight compounds from biological samples. The primary analytical tools for such high-throughput data collection are mass spectrometry (MS), often preceded by chromatographic or electrophoretic separation technologies, and nuclear magnetic resonance spectroscopy (NMR). These technologies produce relatively large and complex data sets that require bioinformaticians, cheminformaticians, biostatisticians, data scientists and computer scientists. Together they develop and apply a wide range of algorithms, software tools, repositories and computational resources to process, analyse, report and store the data and metadata. Increasingly, insights from genomics, epigenomics, transcriptomics, proteomics/protein interactomics and metabolomics are combined, to gain insights into the dynamics of biological processes. Metabolomics activities are well represented within Europe and ELIXIR nodes. Metabolite identification is the area that the community believes will have maximal impact of computational metabolomics and metabolomics data management and will benefit most from interactions with the existing five ELIXIR platforms and where progress will contribute most to other ELIXIR communities. The progress through this integrative Implementation Study will benefit industry and academia alike as metabolite identification is one of the major bottlenecks in metabolomics and resolving this challenge requires a community effort. |
ELIXIR Netherlands, EMBL-EBI, ELIXIR France, ELIXIR UK, ELIXIR Germany, ELIXIR Spain, ELIXIR Sweden, ELIXIR Italy, ELIXIR Estonia, ELIXIR Switzerland, ELIXIR Belgium |
Metabolite Identification
|
Metabolomics aims to provide novel insights into the biochemical reactions of organisms by characterising the presence and concentrations of low molecular weight compounds from biological samples. The primary analytical tools for such high-throughput data collection are mass spectrometry (MS), often preceded by chromatographic or electrophoretic separation technologies, and nuclear magnetic resonance spectroscopy (NMR). These technologies produce relatively large and complex data sets that require bioinformaticians, cheminformaticians, biostatisticians, data scientists and computer scientists. Together they develop and apply a wide range of algorithms, software tools, repositories and computational resources to process, analyse, report and store the data and metadata. Increasingly, insights from genomics, epigenomics, transcriptomics, proteomics/protein interactomics and metabolomics are combined, to gain insights into the dynamics of biological processes. Metabolomics activities are well represented within Europe and ELIXIR nodes. Metabolite identification is the area that the community believes will have maximal impact of computational metabolomics and metabolomics data management and will benefit most from interactions with the existing five ELIXIR platforms and where progress will contribute most to other ELIXIR communities. The progress through this integrative Implementation Study will benefit industry and academia alike as metabolite identification is one of the major bottlenecks in metabolomics and resolving this challenge requires a community effort. |
ELIXIR Netherlands, EMBL-EBI, ELIXIR France, ELIXIR UK, ELIXIR Germany, ELIXIR Spain, ELIXIR Sweden, ELIXIR Italy, ELIXIR Estonia, ELIXIR Switzerland, ELIXIR Belgium |
Metabolite Identification
|
Metabolomics aims to provide novel insights into the biochemical reactions of organisms by characterising the presence and concentrations of low molecular weight compounds from biological samples. The primary analytical tools for such high-throughput data collection are mass spectrometry (MS), often preceded by chromatographic or electrophoretic separation technologies, and nuclear magnetic resonance spectroscopy (NMR). These technologies produce relatively large and complex data sets that require bioinformaticians, cheminformaticians, biostatisticians, data scientists and computer scientists. Together they develop and apply a wide range of algorithms, software tools, repositories and computational resources to process, analyse, report and store the data and metadata. Increasingly, insights from genomics, epigenomics, transcriptomics, proteomics/protein interactomics and metabolomics are combined, to gain insights into the dynamics of biological processes. Metabolomics activities are well represented within Europe and ELIXIR nodes. Metabolite identification is the area that the community believes will have maximal impact of computational metabolomics and metabolomics data management and will benefit most from interactions with the existing five ELIXIR platforms and where progress will contribute most to other ELIXIR communities. The progress through this integrative Implementation Study will benefit industry and academia alike as metabolite identification is one of the major bottlenecks in metabolomics and resolving this challenge requires a community effort. |
ELIXIR Netherlands, EMBL-EBI, ELIXIR France, ELIXIR UK, ELIXIR Germany, ELIXIR Spain, ELIXIR Sweden, ELIXIR Italy, ELIXIR Estonia, ELIXIR Switzerland, ELIXIR Belgium |
Standardising the fluxomics workflows
|
This Metabolomics Community-led project on the standardization of fluxomics workflows aims at:
BackgroundMetabolic reaction rates (fluxes) provide a measure of the in vivo enzymatic activities that cannot be directly available from the transcriptomic, proteomic or metabolomic data alone, even extended with isotopic labeling measurements. However, flux distribution maps and through them, metabolic network dynamics, can be revealed when analyzing these data integrated with regulatory information using multi-level and multi-scale models. In this context, fluxomics is an integral part of the bioinformatics and systems biology toolbox. It has significant applications in industrial biotechnology, metabolic or protein engineering, nutritional systems biology, toxicology, precision agriculture and crop improvement and network and systems medicine for the investigation of (patho)physiological mechanisms of complex diseases. A successful fluxomic analysis is based on the accuracy of quantitative metabolomic data (extra- and intra-cellular) and isotopic labeling measurements and the reconstruction of metabolic networks that describe the stoichiometry - and when available the regulation- of metabolic reactions. To date, the community lacks standardized isotopic labeling data repositories, interoperability among the fluxomic tools and harmonized fluxomic training workflows. In this context, the Metabolomics Community decided to focus its second implementation study on the standardization of fluxomic workflows. GoalsStandardization of the fluxomic workflow requires (a) standardization and FAIRification of the quantitative metabolomic and isotopic labeling data input, (b) standardized reconstruction of metabolic models, based on metabolic reaction databases and ontologies, extended with regulatory information, and (c) interoperability of the various fluxomics tools and the metabolomic and ontology databases. The standardized workflow could be containerized to work in a cloud-based environment. In this implementation study, these objectives will be pursued through the following specific aims:
|
ELIXIR Greece, ELIXIR Spain, ELIXIR Netherlands, ELIXIR Belgium , ELIXIR Italy, ELIXIR Germany, ELIXIR France, ELIXIR UK, EMBL-EBI, ELIXIR Finland, ELIXIR Sweden, ELIXIR Estonia, ELIXIR Switzerland, ELIXIR Greece |
Standardising the fluxomics workflows
|
This Metabolomics Community-led project on the standardization of fluxomics workflows aims at:
BackgroundMetabolic reaction rates (fluxes) provide a measure of the in vivo enzymatic activities that cannot be directly available from the transcriptomic, proteomic or metabolomic data alone, even extended with isotopic labeling measurements. However, flux distribution maps and through them, metabolic network dynamics, can be revealed when analyzing these data integrated with regulatory information using multi-level and multi-scale models. In this context, fluxomics is an integral part of the bioinformatics and systems biology toolbox. It has significant applications in industrial biotechnology, metabolic or protein engineering, nutritional systems biology, toxicology, precision agriculture and crop improvement and network and systems medicine for the investigation of (patho)physiological mechanisms of complex diseases. A successful fluxomic analysis is based on the accuracy of quantitative metabolomic data (extra- and intra-cellular) and isotopic labeling measurements and the reconstruction of metabolic networks that describe the stoichiometry - and when available the regulation- of metabolic reactions. To date, the community lacks standardized isotopic labeling data repositories, interoperability among the fluxomic tools and harmonized fluxomic training workflows. In this context, the Metabolomics Community decided to focus its second implementation study on the standardization of fluxomic workflows. GoalsStandardization of the fluxomic workflow requires (a) standardization and FAIRification of the quantitative metabolomic and isotopic labeling data input, (b) standardized reconstruction of metabolic models, based on metabolic reaction databases and ontologies, extended with regulatory information, and (c) interoperability of the various fluxomics tools and the metabolomic and ontology databases. The standardized workflow could be containerized to work in a cloud-based environment. In this implementation study, these objectives will be pursued through the following specific aims:
|
ELIXIR Greece, ELIXIR Spain, ELIXIR Netherlands, ELIXIR Belgium , ELIXIR Italy, ELIXIR Germany, ELIXIR France, ELIXIR UK, EMBL-EBI, ELIXIR Finland, ELIXIR Sweden, ELIXIR Estonia, ELIXIR Switzerland, ELIXIR Greece |
Standardising the fluxomics workflows
|
This Metabolomics Community-led project on the standardization of fluxomics workflows aims at:
BackgroundMetabolic reaction rates (fluxes) provide a measure of the in vivo enzymatic activities that cannot be directly available from the transcriptomic, proteomic or metabolomic data alone, even extended with isotopic labeling measurements. However, flux distribution maps and through them, metabolic network dynamics, can be revealed when analyzing these data integrated with regulatory information using multi-level and multi-scale models. In this context, fluxomics is an integral part of the bioinformatics and systems biology toolbox. It has significant applications in industrial biotechnology, metabolic or protein engineering, nutritional systems biology, toxicology, precision agriculture and crop improvement and network and systems medicine for the investigation of (patho)physiological mechanisms of complex diseases. A successful fluxomic analysis is based on the accuracy of quantitative metabolomic data (extra- and intra-cellular) and isotopic labeling measurements and the reconstruction of metabolic networks that describe the stoichiometry - and when available the regulation- of metabolic reactions. To date, the community lacks standardized isotopic labeling data repositories, interoperability among the fluxomic tools and harmonized fluxomic training workflows. In this context, the Metabolomics Community decided to focus its second implementation study on the standardization of fluxomic workflows. GoalsStandardization of the fluxomic workflow requires (a) standardization and FAIRification of the quantitative metabolomic and isotopic labeling data input, (b) standardized reconstruction of metabolic models, based on metabolic reaction databases and ontologies, extended with regulatory information, and (c) interoperability of the various fluxomics tools and the metabolomic and ontology databases. The standardized workflow could be containerized to work in a cloud-based environment. In this implementation study, these objectives will be pursued through the following specific aims:
|
ELIXIR Greece, ELIXIR Spain, ELIXIR Netherlands, ELIXIR Belgium , ELIXIR Italy, ELIXIR Germany, ELIXIR France, ELIXIR UK, EMBL-EBI, ELIXIR Finland, ELIXIR Sweden, ELIXIR Estonia, ELIXIR Switzerland, ELIXIR Greece |
Standardising the fluxomics workflows
|
This Metabolomics Community-led project on the standardization of fluxomics workflows aims at:
BackgroundMetabolic reaction rates (fluxes) provide a measure of the in vivo enzymatic activities that cannot be directly available from the transcriptomic, proteomic or metabolomic data alone, even extended with isotopic labeling measurements. However, flux distribution maps and through them, metabolic network dynamics, can be revealed when analyzing these data integrated with regulatory information using multi-level and multi-scale models. In this context, fluxomics is an integral part of the bioinformatics and systems biology toolbox. It has significant applications in industrial biotechnology, metabolic or protein engineering, nutritional systems biology, toxicology, precision agriculture and crop improvement and network and systems medicine for the investigation of (patho)physiological mechanisms of complex diseases. A successful fluxomic analysis is based on the accuracy of quantitative metabolomic data (extra- and intra-cellular) and isotopic labeling measurements and the reconstruction of metabolic networks that describe the stoichiometry - and when available the regulation- of metabolic reactions. To date, the community lacks standardized isotopic labeling data repositories, interoperability among the fluxomic tools and harmonized fluxomic training workflows. In this context, the Metabolomics Community decided to focus its second implementation study on the standardization of fluxomic workflows. GoalsStandardization of the fluxomic workflow requires (a) standardization and FAIRification of the quantitative metabolomic and isotopic labeling data input, (b) standardized reconstruction of metabolic models, based on metabolic reaction databases and ontologies, extended with regulatory information, and (c) interoperability of the various fluxomics tools and the metabolomic and ontology databases. The standardized workflow could be containerized to work in a cloud-based environment. In this implementation study, these objectives will be pursued through the following specific aims:
|
ELIXIR Greece, ELIXIR Spain, ELIXIR Netherlands, ELIXIR Belgium , ELIXIR Italy, ELIXIR Germany, ELIXIR France, ELIXIR UK, EMBL-EBI, ELIXIR Finland, ELIXIR Sweden, ELIXIR Estonia, ELIXIR Switzerland, ELIXIR Greece |
Standardising the fluxomics workflows
|
This Metabolomics Community-led project on the standardization of fluxomics workflows aims at:
BackgroundMetabolic reaction rates (fluxes) provide a measure of the in vivo enzymatic activities that cannot be directly available from the transcriptomic, proteomic or metabolomic data alone, even extended with isotopic labeling measurements. However, flux distribution maps and through them, metabolic network dynamics, can be revealed when analyzing these data integrated with regulatory information using multi-level and multi-scale models. In this context, fluxomics is an integral part of the bioinformatics and systems biology toolbox. It has significant applications in industrial biotechnology, metabolic or protein engineering, nutritional systems biology, toxicology, precision agriculture and crop improvement and network and systems medicine for the investigation of (patho)physiological mechanisms of complex diseases. A successful fluxomic analysis is based on the accuracy of quantitative metabolomic data (extra- and intra-cellular) and isotopic labeling measurements and the reconstruction of metabolic networks that describe the stoichiometry - and when available the regulation- of metabolic reactions. To date, the community lacks standardized isotopic labeling data repositories, interoperability among the fluxomic tools and harmonized fluxomic training workflows. In this context, the Metabolomics Community decided to focus its second implementation study on the standardization of fluxomic workflows. GoalsStandardization of the fluxomic workflow requires (a) standardization and FAIRification of the quantitative metabolomic and isotopic labeling data input, (b) standardized reconstruction of metabolic models, based on metabolic reaction databases and ontologies, extended with regulatory information, and (c) interoperability of the various fluxomics tools and the metabolomic and ontology databases. The standardized workflow could be containerized to work in a cloud-based environment. In this implementation study, these objectives will be pursued through the following specific aims:
|
ELIXIR Greece, ELIXIR Spain, ELIXIR Netherlands, ELIXIR Belgium , ELIXIR Italy, ELIXIR Germany, ELIXIR France, ELIXIR UK, EMBL-EBI, ELIXIR Finland, ELIXIR Sweden, ELIXIR Estonia, ELIXIR Switzerland, ELIXIR Greece |
Standardising the fluxomics workflows
|
This Metabolomics Community-led project on the standardization of fluxomics workflows aims at:
BackgroundMetabolic reaction rates (fluxes) provide a measure of the in vivo enzymatic activities that cannot be directly available from the transcriptomic, proteomic or metabolomic data alone, even extended with isotopic labeling measurements. However, flux distribution maps and through them, metabolic network dynamics, can be revealed when analyzing these data integrated with regulatory information using multi-level and multi-scale models. In this context, fluxomics is an integral part of the bioinformatics and systems biology toolbox. It has significant applications in industrial biotechnology, metabolic or protein engineering, nutritional systems biology, toxicology, precision agriculture and crop improvement and network and systems medicine for the investigation of (patho)physiological mechanisms of complex diseases. A successful fluxomic analysis is based on the accuracy of quantitative metabolomic data (extra- and intra-cellular) and isotopic labeling measurements and the reconstruction of metabolic networks that describe the stoichiometry - and when available the regulation- of metabolic reactions. To date, the community lacks standardized isotopic labeling data repositories, interoperability among the fluxomic tools and harmonized fluxomic training workflows. In this context, the Metabolomics Community decided to focus its second implementation study on the standardization of fluxomic workflows. GoalsStandardization of the fluxomic workflow requires (a) standardization and FAIRification of the quantitative metabolomic and isotopic labeling data input, (b) standardized reconstruction of metabolic models, based on metabolic reaction databases and ontologies, extended with regulatory information, and (c) interoperability of the various fluxomics tools and the metabolomic and ontology databases. The standardized workflow could be containerized to work in a cloud-based environment. In this implementation study, these objectives will be pursued through the following specific aims:
|
ELIXIR Greece, ELIXIR Spain, ELIXIR Netherlands, ELIXIR Belgium , ELIXIR Italy, ELIXIR Germany, ELIXIR France, ELIXIR UK, EMBL-EBI, ELIXIR Finland, ELIXIR Sweden, ELIXIR Estonia, ELIXIR Switzerland, ELIXIR Greece |
Standardising the fluxomics workflows
|
This Metabolomics Community-led project on the standardization of fluxomics workflows aims at:
BackgroundMetabolic reaction rates (fluxes) provide a measure of the in vivo enzymatic activities that cannot be directly available from the transcriptomic, proteomic or metabolomic data alone, even extended with isotopic labeling measurements. However, flux distribution maps and through them, metabolic network dynamics, can be revealed when analyzing these data integrated with regulatory information using multi-level and multi-scale models. In this context, fluxomics is an integral part of the bioinformatics and systems biology toolbox. It has significant applications in industrial biotechnology, metabolic or protein engineering, nutritional systems biology, toxicology, precision agriculture and crop improvement and network and systems medicine for the investigation of (patho)physiological mechanisms of complex diseases. A successful fluxomic analysis is based on the accuracy of quantitative metabolomic data (extra- and intra-cellular) and isotopic labeling measurements and the reconstruction of metabolic networks that describe the stoichiometry - and when available the regulation- of metabolic reactions. To date, the community lacks standardized isotopic labeling data repositories, interoperability among the fluxomic tools and harmonized fluxomic training workflows. In this context, the Metabolomics Community decided to focus its second implementation study on the standardization of fluxomic workflows. GoalsStandardization of the fluxomic workflow requires (a) standardization and FAIRification of the quantitative metabolomic and isotopic labeling data input, (b) standardized reconstruction of metabolic models, based on metabolic reaction databases and ontologies, extended with regulatory information, and (c) interoperability of the various fluxomics tools and the metabolomic and ontology databases. The standardized workflow could be containerized to work in a cloud-based environment. In this implementation study, these objectives will be pursued through the following specific aims:
|
ELIXIR Greece, ELIXIR Spain, ELIXIR Netherlands, ELIXIR Belgium , ELIXIR Italy, ELIXIR Germany, ELIXIR France, ELIXIR UK, EMBL-EBI, ELIXIR Finland, ELIXIR Sweden, ELIXIR Estonia, ELIXIR Switzerland, ELIXIR Greece |
Standardising the fluxomics workflows
|
This Metabolomics Community-led project on the standardization of fluxomics workflows aims at:
BackgroundMetabolic reaction rates (fluxes) provide a measure of the in vivo enzymatic activities that cannot be directly available from the transcriptomic, proteomic or metabolomic data alone, even extended with isotopic labeling measurements. However, flux distribution maps and through them, metabolic network dynamics, can be revealed when analyzing these data integrated with regulatory information using multi-level and multi-scale models. In this context, fluxomics is an integral part of the bioinformatics and systems biology toolbox. It has significant applications in industrial biotechnology, metabolic or protein engineering, nutritional systems biology, toxicology, precision agriculture and crop improvement and network and systems medicine for the investigation of (patho)physiological mechanisms of complex diseases. A successful fluxomic analysis is based on the accuracy of quantitative metabolomic data (extra- and intra-cellular) and isotopic labeling measurements and the reconstruction of metabolic networks that describe the stoichiometry - and when available the regulation- of metabolic reactions. To date, the community lacks standardized isotopic labeling data repositories, interoperability among the fluxomic tools and harmonized fluxomic training workflows. In this context, the Metabolomics Community decided to focus its second implementation study on the standardization of fluxomic workflows. GoalsStandardization of the fluxomic workflow requires (a) standardization and FAIRification of the quantitative metabolomic and isotopic labeling data input, (b) standardized reconstruction of metabolic models, based on metabolic reaction databases and ontologies, extended with regulatory information, and (c) interoperability of the various fluxomics tools and the metabolomic and ontology databases. The standardized workflow could be containerized to work in a cloud-based environment. In this implementation study, these objectives will be pursued through the following specific aims:
|
ELIXIR Greece, ELIXIR Spain, ELIXIR Netherlands, ELIXIR Belgium , ELIXIR Italy, ELIXIR Germany, ELIXIR France, ELIXIR UK, EMBL-EBI, ELIXIR Finland, ELIXIR Sweden, ELIXIR Estonia, ELIXIR Switzerland, ELIXIR Greece |
Standardising the fluxomics workflows
|
This Metabolomics Community-led project on the standardization of fluxomics workflows aims at:
BackgroundMetabolic reaction rates (fluxes) provide a measure of the in vivo enzymatic activities that cannot be directly available from the transcriptomic, proteomic or metabolomic data alone, even extended with isotopic labeling measurements. However, flux distribution maps and through them, metabolic network dynamics, can be revealed when analyzing these data integrated with regulatory information using multi-level and multi-scale models. In this context, fluxomics is an integral part of the bioinformatics and systems biology toolbox. It has significant applications in industrial biotechnology, metabolic or protein engineering, nutritional systems biology, toxicology, precision agriculture and crop improvement and network and systems medicine for the investigation of (patho)physiological mechanisms of complex diseases. A successful fluxomic analysis is based on the accuracy of quantitative metabolomic data (extra- and intra-cellular) and isotopic labeling measurements and the reconstruction of metabolic networks that describe the stoichiometry - and when available the regulation- of metabolic reactions. To date, the community lacks standardized isotopic labeling data repositories, interoperability among the fluxomic tools and harmonized fluxomic training workflows. In this context, the Metabolomics Community decided to focus its second implementation study on the standardization of fluxomic workflows. GoalsStandardization of the fluxomic workflow requires (a) standardization and FAIRification of the quantitative metabolomic and isotopic labeling data input, (b) standardized reconstruction of metabolic models, based on metabolic reaction databases and ontologies, extended with regulatory information, and (c) interoperability of the various fluxomics tools and the metabolomic and ontology databases. The standardized workflow could be containerized to work in a cloud-based environment. In this implementation study, these objectives will be pursued through the following specific aims:
|
ELIXIR Greece, ELIXIR Spain, ELIXIR Netherlands, ELIXIR Belgium , ELIXIR Italy, ELIXIR Germany, ELIXIR France, ELIXIR UK, EMBL-EBI, ELIXIR Finland, ELIXIR Sweden, ELIXIR Estonia, ELIXIR Switzerland, ELIXIR Greece |
Standardising the fluxomics workflows
|
This Metabolomics Community-led project on the standardization of fluxomics workflows aims at:
BackgroundMetabolic reaction rates (fluxes) provide a measure of the in vivo enzymatic activities that cannot be directly available from the transcriptomic, proteomic or metabolomic data alone, even extended with isotopic labeling measurements. However, flux distribution maps and through them, metabolic network dynamics, can be revealed when analyzing these data integrated with regulatory information using multi-level and multi-scale models. In this context, fluxomics is an integral part of the bioinformatics and systems biology toolbox. It has significant applications in industrial biotechnology, metabolic or protein engineering, nutritional systems biology, toxicology, precision agriculture and crop improvement and network and systems medicine for the investigation of (patho)physiological mechanisms of complex diseases. A successful fluxomic analysis is based on the accuracy of quantitative metabolomic data (extra- and intra-cellular) and isotopic labeling measurements and the reconstruction of metabolic networks that describe the stoichiometry - and when available the regulation- of metabolic reactions. To date, the community lacks standardized isotopic labeling data repositories, interoperability among the fluxomic tools and harmonized fluxomic training workflows. In this context, the Metabolomics Community decided to focus its second implementation study on the standardization of fluxomic workflows. GoalsStandardization of the fluxomic workflow requires (a) standardization and FAIRification of the quantitative metabolomic and isotopic labeling data input, (b) standardized reconstruction of metabolic models, based on metabolic reaction databases and ontologies, extended with regulatory information, and (c) interoperability of the various fluxomics tools and the metabolomic and ontology databases. The standardized workflow could be containerized to work in a cloud-based environment. In this implementation study, these objectives will be pursued through the following specific aims:
|
ELIXIR Greece, ELIXIR Spain, ELIXIR Netherlands, ELIXIR Belgium , ELIXIR Italy, ELIXIR Germany, ELIXIR France, ELIXIR UK, EMBL-EBI, ELIXIR Finland, ELIXIR Sweden, ELIXIR Estonia, ELIXIR Switzerland, ELIXIR Greece |
Standardising the fluxomics workflows
|
This Metabolomics Community-led project on the standardization of fluxomics workflows aims at:
BackgroundMetabolic reaction rates (fluxes) provide a measure of the in vivo enzymatic activities that cannot be directly available from the transcriptomic, proteomic or metabolomic data alone, even extended with isotopic labeling measurements. However, flux distribution maps and through them, metabolic network dynamics, can be revealed when analyzing these data integrated with regulatory information using multi-level and multi-scale models. In this context, fluxomics is an integral part of the bioinformatics and systems biology toolbox. It has significant applications in industrial biotechnology, metabolic or protein engineering, nutritional systems biology, toxicology, precision agriculture and crop improvement and network and systems medicine for the investigation of (patho)physiological mechanisms of complex diseases. A successful fluxomic analysis is based on the accuracy of quantitative metabolomic data (extra- and intra-cellular) and isotopic labeling measurements and the reconstruction of metabolic networks that describe the stoichiometry - and when available the regulation- of metabolic reactions. To date, the community lacks standardized isotopic labeling data repositories, interoperability among the fluxomic tools and harmonized fluxomic training workflows. In this context, the Metabolomics Community decided to focus its second implementation study on the standardization of fluxomic workflows. GoalsStandardization of the fluxomic workflow requires (a) standardization and FAIRification of the quantitative metabolomic and isotopic labeling data input, (b) standardized reconstruction of metabolic models, based on metabolic reaction databases and ontologies, extended with regulatory information, and (c) interoperability of the various fluxomics tools and the metabolomic and ontology databases. The standardized workflow could be containerized to work in a cloud-based environment. In this implementation study, these objectives will be pursued through the following specific aims:
|
ELIXIR Greece, ELIXIR Spain, ELIXIR Netherlands, ELIXIR Belgium , ELIXIR Italy, ELIXIR Germany, ELIXIR France, ELIXIR UK, EMBL-EBI, ELIXIR Finland, ELIXIR Sweden, ELIXIR Estonia, ELIXIR Switzerland, ELIXIR Greece |
Standardising the fluxomics workflows
|
This Metabolomics Community-led project on the standardization of fluxomics workflows aims at:
BackgroundMetabolic reaction rates (fluxes) provide a measure of the in vivo enzymatic activities that cannot be directly available from the transcriptomic, proteomic or metabolomic data alone, even extended with isotopic labeling measurements. However, flux distribution maps and through them, metabolic network dynamics, can be revealed when analyzing these data integrated with regulatory information using multi-level and multi-scale models. In this context, fluxomics is an integral part of the bioinformatics and systems biology toolbox. It has significant applications in industrial biotechnology, metabolic or protein engineering, nutritional systems biology, toxicology, precision agriculture and crop improvement and network and systems medicine for the investigation of (patho)physiological mechanisms of complex diseases. A successful fluxomic analysis is based on the accuracy of quantitative metabolomic data (extra- and intra-cellular) and isotopic labeling measurements and the reconstruction of metabolic networks that describe the stoichiometry - and when available the regulation- of metabolic reactions. To date, the community lacks standardized isotopic labeling data repositories, interoperability among the fluxomic tools and harmonized fluxomic training workflows. In this context, the Metabolomics Community decided to focus its second implementation study on the standardization of fluxomic workflows. GoalsStandardization of the fluxomic workflow requires (a) standardization and FAIRification of the quantitative metabolomic and isotopic labeling data input, (b) standardized reconstruction of metabolic models, based on metabolic reaction databases and ontologies, extended with regulatory information, and (c) interoperability of the various fluxomics tools and the metabolomic and ontology databases. The standardized workflow could be containerized to work in a cloud-based environment. In this implementation study, these objectives will be pursued through the following specific aims:
|
ELIXIR Greece, ELIXIR Spain, ELIXIR Netherlands, ELIXIR Belgium , ELIXIR Italy, ELIXIR Germany, ELIXIR France, ELIXIR UK, EMBL-EBI, ELIXIR Finland, ELIXIR Sweden, ELIXIR Estonia, ELIXIR Switzerland, ELIXIR Greece |
Standardising the fluxomics workflows
|
This Metabolomics Community-led project on the standardization of fluxomics workflows aims at:
BackgroundMetabolic reaction rates (fluxes) provide a measure of the in vivo enzymatic activities that cannot be directly available from the transcriptomic, proteomic or metabolomic data alone, even extended with isotopic labeling measurements. However, flux distribution maps and through them, metabolic network dynamics, can be revealed when analyzing these data integrated with regulatory information using multi-level and multi-scale models. In this context, fluxomics is an integral part of the bioinformatics and systems biology toolbox. It has significant applications in industrial biotechnology, metabolic or protein engineering, nutritional systems biology, toxicology, precision agriculture and crop improvement and network and systems medicine for the investigation of (patho)physiological mechanisms of complex diseases. A successful fluxomic analysis is based on the accuracy of quantitative metabolomic data (extra- and intra-cellular) and isotopic labeling measurements and the reconstruction of metabolic networks that describe the stoichiometry - and when available the regulation- of metabolic reactions. To date, the community lacks standardized isotopic labeling data repositories, interoperability among the fluxomic tools and harmonized fluxomic training workflows. In this context, the Metabolomics Community decided to focus its second implementation study on the standardization of fluxomic workflows. GoalsStandardization of the fluxomic workflow requires (a) standardization and FAIRification of the quantitative metabolomic and isotopic labeling data input, (b) standardized reconstruction of metabolic models, based on metabolic reaction databases and ontologies, extended with regulatory information, and (c) interoperability of the various fluxomics tools and the metabolomic and ontology databases. The standardized workflow could be containerized to work in a cloud-based environment. In this implementation study, these objectives will be pursued through the following specific aims:
|
ELIXIR Greece, ELIXIR Spain, ELIXIR Netherlands, ELIXIR Belgium , ELIXIR Italy, ELIXIR Germany, ELIXIR France, ELIXIR UK, EMBL-EBI, ELIXIR Finland, ELIXIR Sweden, ELIXIR Estonia, ELIXIR Switzerland, ELIXIR Greece |
Standardising the fluxomics workflows
|
This Metabolomics Community-led project on the standardization of fluxomics workflows aims at:
BackgroundMetabolic reaction rates (fluxes) provide a measure of the in vivo enzymatic activities that cannot be directly available from the transcriptomic, proteomic or metabolomic data alone, even extended with isotopic labeling measurements. However, flux distribution maps and through them, metabolic network dynamics, can be revealed when analyzing these data integrated with regulatory information using multi-level and multi-scale models. In this context, fluxomics is an integral part of the bioinformatics and systems biology toolbox. It has significant applications in industrial biotechnology, metabolic or protein engineering, nutritional systems biology, toxicology, precision agriculture and crop improvement and network and systems medicine for the investigation of (patho)physiological mechanisms of complex diseases. A successful fluxomic analysis is based on the accuracy of quantitative metabolomic data (extra- and intra-cellular) and isotopic labeling measurements and the reconstruction of metabolic networks that describe the stoichiometry - and when available the regulation- of metabolic reactions. To date, the community lacks standardized isotopic labeling data repositories, interoperability among the fluxomic tools and harmonized fluxomic training workflows. In this context, the Metabolomics Community decided to focus its second implementation study on the standardization of fluxomic workflows. GoalsStandardization of the fluxomic workflow requires (a) standardization and FAIRification of the quantitative metabolomic and isotopic labeling data input, (b) standardized reconstruction of metabolic models, based on metabolic reaction databases and ontologies, extended with regulatory information, and (c) interoperability of the various fluxomics tools and the metabolomic and ontology databases. The standardized workflow could be containerized to work in a cloud-based environment. In this implementation study, these objectives will be pursued through the following specific aims:
|
ELIXIR Greece, ELIXIR Spain, ELIXIR Netherlands, ELIXIR Belgium , ELIXIR Italy, ELIXIR Germany, ELIXIR France, ELIXIR UK, EMBL-EBI, ELIXIR Finland, ELIXIR Sweden, ELIXIR Estonia, ELIXIR Switzerland, ELIXIR Greece |